Require the complete analogue designation
A document headed only IGF-1 does not establish that it characterizes the LR3 reference in this catalog. Do not treat a different IGF-related product as the same material for pricing or evidence review.
Documentation to request
Request the sequence or structural specification, analytical identity methods and intended laboratory application. Keep any finished-medicine approval record separate.
Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Hormone clinic purchasing review. These references support a review, not a treatment recommendation or supply authorization.